Skip to content

Study of Home-Embedded Palliative Care for Hemodialysis-Dependent End-Stage Renal Disease

Study of Home-Embedded Palliative Care for Hemodialysis-Dependent End-Stage Renal Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05471622
Acronym
SHEPHERD
Enrollment
285
Registered
2022-07-25
Start date
2022-07-21
Completion date
2023-12-18
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-Stage Renal Disease

Keywords

palliative, ESRD

Brief summary

Home palliative care needs are often under-recognized in patients with End-Stage Renal Disease (ESRD). This pilot study is designed to evaluate the feasibility and acceptability of an initiative to enhance referrals to Penn Home Palliative Care compared with usual care among hemodialysis-dependent ESRD patients admitted to a Penn hospital. Results will inform a future pragmatic trial comparing the effectiveness of home palliative care compared with usual care among ESRD patients. Evaluating the effectiveness of home palliative care services is critical to determine whether increasing access to these services would improve patient-centered outcomes for these high-need patients.

Interventions

BEHAVIORALNudge for PHPC Referral

The case manager and covering providers for inpatients who have been identified according to the study's inclusion criteria as appropriate for Penn Home Palliative Care (PHPC) upon hospital discharge will be asked to refer their patient for these home palliative care services.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be an adult (18 years of age or older) hospitalized at one of two study hospitals * Digital signature of ESRD (N18.6) within the last 12 months with an inpatient hemodialysis order * Patient resides in the five-county area surrounding Philadelphia which is served by the Penn Home Palliative Care services. * Appropriate for home palliative care, defined as: (i) Existing home care eligibility/referral for home care OR (ii) Severe protein malnutrition (E43, E44) OR (iii) Non-ambulatory status determined by a flowsheet completed by nursing on hospital admission with three ambulatory options: (1) non-ambulatory, (2) ambulates with assistance, or (3) ambulates independently. If this information is missing from the electronic health record, the determination will be made using one of the three following options: (1) overall prior home mobility assessment complete dependence on all aspects, or (2) ambulation or functional transfers domains indicate dependent, or (3) wheelchair mobility domain was completed (with any non-null/non-empty value).

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Rate of Home Palliative Care ReceiptBaseline - 45 daysReceipt of home palliative care will be defined as at least one home palliative care visit within 45 days after hospital discharge, determined via electronic health record review.

Secondary

MeasureTime frameDescription
Follow-up Home Palliative Care VisitsBaseline - 180 daysThe total number of home palliative care visits during the 180-day follow-up period after hospital discharge will be assessed using the electronic health record.
MortalityBaseline - 180 daysMortality rates will be assessed using the electronic health record after the 180-day follow-up period.
Hospital-free daysBaseline - 180 daysThe number of hospital-free days during the 180-day follow-up period will be assessed using the electronic health record and administrative data for the tri-state area.
Acceptability of home palliative care referral among clinician stakeholdersBaseline - 180 daysAcceptability of home palliative care referral among clinician stakeholders will be measured via survey and focus group questions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026